| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.29B | +11.1% |
| Gross Profit | $300.7M | +5.4% |
| R&D Expense | $10.8M | +10.6% |
| SG&A Expense | $46.6M | -37.0% |
| Operating Income | $145.0M | +11.0% |
| Pre-tax Income | $161.2M | +14.6% |
| Income Tax | $23.8M | +60.9% |
| Net Income | $137.4M | +9.2% |
| EPS (Basic) | $3.60 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $379.8M | +46.2% |
| Short-term Investments | $36.3M | -14.9% |
| Accounts Receivable | $66.0M | +15.1% |
| Inventory | $188.3M | +9.2% |
| Current Assets | $690.7M | +26.1% |
| Total Assets | $1.20B | +12.3% |
| Current Liabilities | $342.2M | +29.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $190.7M | +20.6% |
| Capital Expenditures | $7.9M | -49.3% |
| Investing Cash Flow | -$5.1M | +90.8% |
| Financing Cash Flow | -$67.8M | -171.5% |
| Free Cash Flow | $182.8M | +28.2% |
| +17.6% |
| EPS (Diluted) | $3.59 | +17.7% |
| Total Liabilities |
| $716.7M |
| +7.7% |
| Stockholders' Equity | $485.8M | +19.9% |